Condition
Reticular Veins
Total Trials
3
Recruiting
1
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Active Not Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07793630Phase 4Active Not Recruiting
Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias
NCT07678697Not ApplicableRecruiting
Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique
NCT07162844Not ApplicableActive Not Recruiting
Foam and Liquid Sclerotherapy With or Without Herbal Gel for Small Vein Treatment
Showing all 3 trials